Compounds > aspirin

aspirin and omacor

aspirin has been researched along with omacor in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beller, E; Cass, A; Dogra, G; Hawley, C; Heritier, S; Irish, A; Kerr, P; Mori, T; Paul-Brent, PA; Polkinghorne, K; Robertson, A; Rosman, J; Starfield, M1
Chmiel, A; Gąsior, Z; Gieszczyk-Strózik, K; Haberka, M; Kyrcz-Krzemień, S; Lasota, B; Mizia, M; Mizia-Stec, K; Najda, J1
Badve, SV; Cass, A; Hawley, C; Heritier, S; Irish, AB; Kerr, PG; Mori, TA; Pascoe, E; Paul-Brent, PA; Polkinghorne, KR; Robertson, A; Seong, HL; Viecelli, AK1
Badve, SV; Cass, A; Hawley, CM; Hooi, SL; Irish, AB; Johnson, DW; Kerr, PG; Mori, TA; Ong, ML; Pascoe, EM; Paul-Brent, PA; Polkinghorne, KR; Scaria, A; Viecelli, AK1
Chiang, N; Colas, RA; Dalli, J; Elajami, TK; Serhan, CN; Welty, FK1

Trials

5 trial(s) available for aspirin and omacor

ArticleYear
Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.
    BMC nephrology, 2009, Jan-21, Volume: 10

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arteriovenous Shunt, Surgical; Aspirin; Clinical Protocols; Docosahexaenoic Acids; Double-Blind Method; Drug Combinations; Eicosapentaenoic Acid; Humans; Kidney Failure, Chronic; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Thrombosis; Vascular Patency

2009
N-3 polyunsaturated fatty acids do not influence the efficacy of dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention.
    Cardiology journal, 2013, Volume: 20, Issue:5

    Topics: Aged; Angina, Stable; Aspirin; Blood Platelets; Clopidogrel; Docosahexaenoic Acids; Drug Combinations; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Poland; Prospective Studies; Ticlopidine; Time Factors; Treatment Outcome

2013
The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications.
    BMC nephrology, 2015, Jun-27, Volume: 16

    Topics: Arteriovenous Shunt, Surgical; Aspirin; Central Venous Catheters; Docosahexaenoic Acids; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Fish Oils; Humans; Kidney Failure, Chronic; Platelet Aggregation Inhibitors; Postoperative Complications; Renal Dialysis; Renal Insufficiency, Chronic; Thrombosis

2015
Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.
    Nephrology (Carlton, Vic.), 2016, Volume: 21, Issue:3

    Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Australia; Comorbidity; Docosahexaenoic Acids; Double-Blind Method; Drug Combinations; Eicosapentaenoic Acid; Female; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Malaysia; Male; Middle Aged; New Zealand; Prevalence; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Severity of Illness Index; Thrombosis; Time Factors; Treatment Outcome; United Kingdom; Vascular Patency

2016
Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2016, Volume: 30, Issue:8

    Topics: Aged; Aspirin; Biomarkers; Coronary Disease; Docosahexaenoic Acids; Drug Combinations; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Gene Expression Regulation; Humans; Lipid Metabolism; Lipoxins; Male; Middle Aged; Platelet Aggregation Inhibitors

2016